ArticleBiomimetics (Basel, Switzerland)2026
Value-Gradient Generalist Design of Muscle-Tendon Parameters for Cross-Terrain Musculoskeletal Locomotion.
Article in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Compliant muscle-tendon mechanics can improve terrain adaptation in musculoskeletal robots, but heterogeneous terrains impose competing requirements on compliance, propulsion, foot clearance, and support transfer. This paper proposes Value-Gradient Generalist Design (VGGD), a framework for selecting one fixed physiological muscle-tendon parameterization for cross-terrain locomotion while preserving skeletal topology and muscle routing. VGGD searches a compact PCA-based manifold that coordinates bounded scale factors for muscle strength, contraction-velocity capacity, and passive elastic response. A design- and terrain-conditioned value proxy is learned from sampled latent designs and then optimized by proximity-regularized projected value-gradient ascent under a soft-worst objective. Independent proxy validation uses 50 random designs solely for calibration and 100 separately sampled test designs excluded from fitting and Stage-B optimization. On the 100-design test set, the proxy shows positive agreement with mean cross-terrain return (Pearson r=0.580, Spearman ρ=0.565) and worst-terrain return (r=0.583, ρ=0.551), with all bootstrap intervals above zero and Holm-adjusted permutation p=0.0006. A separate paired local-direction test uses 60 previously unused evaluation seeds and equal feasible-space perturbation radii; at the nominal, midpoint, and selected designs, the proxy-gradient direction agrees with improvements in mean and seed-wise worst-terrain rollout return. After design selection, the muscle-tendon parameters are fixed, and a terrain-aware controller is trained with variational information-bottleneck regularization and auxiliary expert distillation. Checkpoint-resolved evaluation records identify 216/300 successes and an overall mean distance of 12.14 m for the complete pipeline, compared with 57/300 and 6.20 m for nominal-body PPO. The three checkpoint success rates are 84%, 78%, and 54% for Proposed and 49%, 0%, and 8% for PPO; exact two-sided policy-level permutation tests yield p=0.10 for success rate and p=0.20 for mean distance. All methods receive the same nominal 100-million-step final-controller budget per training run, while the 10 M Stage-A budget and expert-pretraining costs are reported separately.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.